Atlas Trials

Her2-negative Metastatic Breast Cancer

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Her2-negative Metastatic Breast Cancer

RecordFirmDate
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management (NCT05362760)Prof. Wolfgang Janni2022-04-27
A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer (NCT05261269)Dantari, Inc.2022-02-02
Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer (NCT04720729)Institut Curie2021-04-21
Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer (NCT03430518)Amy Tiersten2018-05-17
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer (NCT02605915)Hoffmann-La Roche2015-12-31
Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer (NCT01948843)Polaris Group2014-04-01
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs (NCT01619111)Prof. Wolfgang Janni2012-02-01
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (NCT01520103)AIO-Studien-gGmbH2012-01-01

Track Her2-negative Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.